BGLC: BioNexus Gene Lab Bozor narxining sof foydaga nisbati
BioNexus Gene Lab Corp. (BGLC) genetik testlarni joriy etish orqali Janubi-Sharqiy Osiyoning onkologiyani erta aniqlash segmentida ustunlikka intilmoqda. GURU.Markets platformasidagi savdo dinamikasini aks ettiruvchi ushbu narxlar grafigi P/E koeffitsiyenti -0.80 ekanligini ko'rsatmoqda. Biznesning barqarorligi Malayziya laboratoriyalariga tayanadi, tezkor diagnostikani ishlab chiqishdagi texnologik ustunlik esa kompaniyani mintaqaviy raqobatchilarning dumping strategiyalaridan himoya qiladi.
BioNexus Gene Lab Corp (BGLC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati BioNexus Gene Lab Corp.|BGLC - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti BioNexus Gene Lab Corporation|BGLC - Kompaniya qarzlari|Balans qiymatiga qarzlar BioNexus Gene Lab Corp.|BGLC - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi BioNexus Gene Lab|Shoshilinch likvidlik bionexusgenelab.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
BGLC - Sof daromad|Sof foyda prognozi BioNexus Gene Lab Corp.|BGLC - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori BioNexus Gene Lab Corporation|BGLC - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati BioNexus Gene Lab Corp.|BGLC - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda BioNexus Gene Lab|BGLC - Bir aksiya uchun sof foyda (EPS TTM)|Sirpanuvchi yil uchun bir aksiya uchun sof foyda o'sishi bionexusgenelab.com|BGLC - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi BioNexus Gene Lab Corp.
Kompaniyaning har tomonlama tahlili:BGLC (bionexusgenelab.com)
Janubiy-Sharqiy Osiyoda genetik diagnostikaning kengayishi va R&D xarajatlariga oid qiyinchiliklar BioNexus Gene Lab Corp. (BGLC) ning sof foydasiga bevosita ta'sir ko'rsatmoqda. Biznes qiymatini yillik daromadlariga nisbatan aks ettiruvchi ushbu ko'rsatkich aktivning haddan tashqari sotib olingan holatini baholash imkonini beradi, bu esa kompaniyaning kutilayotgan P/E koeffitsienti orqali aniq ko'rinadi va bozor korreksiyasi paytida kirish nuqtasini aniqlashga yordam beradi.
Raqobatdosh kompaniyalar tahlili
linde.com (LIN) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti APD (Air Products and Chemicals)|Bozor narxining sof foydaga nisbati DD|Narxning foydaga nisbati International Paper Corp IP|Kompaniya qiymatining sof foydaga nisbati PPG|DOW: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati lyondellbasell.com|IFF: P/E multiplikatori|RPM (RPM International Inc) - Narxning foydaga nisbati|ENTG (Entegris Corp) - P/E multiplikatori|Suzano Group (SUZ) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Westlake Corporation (WLK)|ALB - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati ICL Group ICL|NEU: Narx-foyda multiplikatori|Eastman Chemical Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Axalta Corp|ESI (Element Solutions Inc) - Narx-foyda koeffitsiyenti|Narx-foyda multiplikatori SQM|Narx-foyda koeffitsiyenti CE|P/E multiplikatori Sensient Technologies Corporation|Narxning foydaga nisbati Cabot Microelectronics (CBT)|Biznesning o‘zini qoplash muddati Hawkins Corp|Avient Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati FUL|Methanex - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti WD-40 Co. (WDFC)|CC: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Quaker Chemical Corp. (KWR)|Narxning foydaga nisbati PureCycle Technologies|Narx-foyda multiplikatori ASH (ashland.com)|P/E multiplikatori NGVT|IOSP - Kapitalizatsiyaning foydaga nisbati|Minerals Tech - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati DQ|SLVM - Narxning foydaga nisbati|HUN: Narxning foydaga nisbati|AIN: P/E multiplikatori|Calumet Specialty Products Partners, L.P. (CLMT) - P/E multiplikatori|ROG (Rogers Advanced Electronics) - P/E multiplikatori|Narxning foydaga nisbati SCL|Narx-foyda koeffitsiyenti ECVT (Ecovyst Inc.)|NEO (neogenomics.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori REX (REX American Resources Corporation)|ASPI - Narx-foyda koeffitsiyenti|TROX - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Ferroglobe Group|Westlake Chemical Partners (WLKP) - Narxning foydaga nisbati|compassminerals.com - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Kronos Worldwide|Mativ Holdings Inc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti LXU (LSB Corp)|Biznesning o‘zini qoplash muddati Braskem Corp|P/E multiplikatori KOP (Koppers Holdings Inc.)|advansix.com - Narxning foydaga nisbati|Orion - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Rayonier Advanced Materials (RYAM)|Aduro Corp (ADUR) - Narxning foydaga nisbati|MAGN (Magnera Group) - Narxning foydaga nisbati|CLW (Clearwater Paper) - P/E multiplikatori|Narx-foyda koeffitsiyenti Tredegar Corp. (TG)|P/E multiplikatori CMT|Narx-foyda koeffitsiyenti FutureFuel Corp FF|P/E multiplikatori FSI (Flexible Solutions International)|Kompaniya qiymatining sof foydaga nisbati ALTO|5E Boron - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Trinseo PLC|originmaterials.com (ORGN) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Northern Technologies International Corporation|LNZA (LanzaTech Global Inc) - P/E multiplikatori|J-Star (YMAT) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati New Era Energy & Digital (NUAI)|Biznesning o‘zini qoplash muddati boltthreads.com|Gulf Resources - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati CNEY (CN Energy Group Inc.)|ALTM - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati DNMR (Danimer Scientific, Inc)|GLT (glatfelter.com) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Graphex Group (GRFX)|SLCA (U.S. Silica) - P/E multiplikatori|Narxning foydaga nisbati IZTC
